You are here

Article Text

Article menu

Download PDFPDF

Other topics
Regulation of pleitropic effect of TRAIL on RAFLS by TRAIL-R1 and -R2
Free
  1. R Audo,
  2. A Bruyer,
  3. B Combe,
  4. M Hahne,
  5. J Morel
  1. Department of Immuno-rheumatology, CHU Lapeyronie, Montpellier, France

https://doi.org/10.1136/ard.2010.129643s

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Rationale Induction of apoptosis in fibroblast-like synoviocytes (FLS) has been proposed as a therapeutic approach. Tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has been described as a pro-apoptotic factor on rheumatoid arthritis FLS (RAFLS) and suggested as a potential drug. We have previously shown that exposure to TRAIL induces apoptosis only in a portion of RAFLS. In the surviving cells, TRAIL induced RAFLS proliferation. To evaluate possibilities to overcome TRAIL resistance in RAFLS, we compared FLS resistant (RAFLS-R) and FLS sensitive (RAFLS-S) to TRAIL-induced apoptosis including expression levels of the TRAIL receptors (TRAIL-R).

    Material and Methods

    Cell surface expression of the four membrane-bound TRAIL-R was measured by FACS. To examine the implication of TRAIL-R in TRAIL apoptosis and proliferation, RAFLS were transfected with siRNA against TRAIL-R1 and TRAIL-R2. After 3 days, efficiency of silencing was assessed by western blot and FACS analysis and cells were cultured with TRAIL for another 24 h. Apoptosis was analysed by flow cytometry using annexin V-FITC binding and TOPRO-3 uptake. Proliferation was measured using incorporation of [3H] thymidine.

    Results

    Depending on the patient, we observed inter-individual variability in sensitivity of RAFLS to TRAIL-induced apoptosis. We therefore classified the cultures depending on their sensitivity (<10%; RAFLS-R and >30%, RAFLS-S). We observed significantly higher expression of TRAIL-R4 and TRAIL-R1 in RAFLS-R (p=0.08 and p=0.14 respectively). Silencing of TRAIL-R2 significantly reduced TRAIL-induced apoptosis or proliferation (25.2±2.6 to 8.9±5.9; p<0.01). In contrast, silencing of TRAIL-R1 sensitised RAFLS for TRAIL-induced apoptosis (25.2±2.6 to 35.8±6.7; p<0.05) but had no influence on TRAIL-induced proliferation.

    Conclusion

    Using siRNA silencing, we confirmed the implication of TRAIL-R2 in apoptosis and proliferation induced by TRAIL. We also found that TRAIL-R1 is not involved in RAFLS apoptosis or proliferation induced by TRAIL but, surprisingly, appears to be a survival factor protecting RAFLS against TRAIL-induced apoptosis. This is consistent with our observation that TRAIL-R1 is significantly more expressed in the cell surface of RAFLS-R.